China maintains focus on APIs with new guidance
China’s antitrust authority has indicated that enforcement against active pharmaceutical ingredient suppliers will remain a priority after releasing sector-specific guidance for only the second time in its history.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10